Tasquinimod: A Novel Angiogenesis Inhibitor–Development in Prostate Cancer Saby GeorgeRoberto Pili Evolving Therapies (RM Bukowski, Section Editor) 20 January 2013 Pages: 65 - 68
Enzalutamide, a Second Generation Androgen Receptor Antagonist: Development and Clinical Applications in Prostate Cancer Manoj P. MenonCelestia S. Higano Evolving Therapies (RM Bukowski, Section Editor) 23 January 2013 Pages: 69 - 75
Cabozantinib as a Novel Therapy for Renal Cell Carcinoma Ulka Vaishampayan Evolving Therapies (RM Bukowski, Section Editor) 05 January 2013 Pages: 76 - 82
Foretinib (XL880): c-MET Inhibitor with Activity in Papillary Renal Cell Cancer Theodore F. Logan Evolving Therapies (RM Bukowski, Section Editor) 14 February 2013 Pages: 83 - 90
Regorafenib (BAY 73–4506): Stromal and Oncogenic Multikinase Inhibitor with Potential Activity in Renal Cell Carcinoma Kamarul ZakiShahzeena AslamTim Eisen Evolving Therapies (RM Bukowski, Section Editor) 20 January 2013 Pages: 91 - 97
Programmed Death 1 Pathway inhibition in Metastatic Renal Cell Cancer and Prostate Cancer Patricia A. TangDaniel Y. C. Heng Evolving Therapies (RM Bukowski, Section Editor) 22 December 2012 Pages: 98 - 104
Targeting the Adrenal Gland in Castration-Resistant Prostate Cancer: A Case for Orteronel, a Selective CYP-17 17,20-Lyase Inhibitor Hui ZhuJorge A. Garcia Evolving Therapies (RM Bukowski, Section Editor) 31 January 2013 Pages: 105 - 112
Custirsen (OGX-011): Clusterin Inhibitor in Metastatic Prostate Cancer Sohaib Al-AsaaedEric Winquist Evolving Therapies (RM Bukowski, Section Editor) 25 December 2012 Pages: 113 - 118
Assessment of Treatment Response after Chemoradiation of Head and Neck Cancer Fernando Luiz Dias Head and Neck Cancers (EY Hanna, Section Editor) 08 January 2013 Pages: 119 - 127
Perineural Invasion of Head and Neck Skin Cancer: Diagnostic and Therapeutic Implications Benedict PanizzaTimothy Warren Head and Neck Cancers (EY Hanna, Section Editor) 27 December 2012 Pages: 128 - 133
Transoral Microsurgery for Treatment of Laryngeal and Pharyngeal Cancers Carlos SuárezJuan P. Rodrigo Head and Neck Cancers (EY Hanna, Section Editor) 30 December 2012 Pages: 134 - 141
Efficacy of Neck Dissection in the Management of Isolated Nodal Recurrence after Head and Neck Cancer Treatment Jimmy Yu–wai Chan Head and Neck Cancers (EY Hanna, Section Editor) 15 January 2013 Pages: 142 - 145
Adjuvant Therapy in Gastric Cancer: What Is The Optimal Approach? Takashi TaketaKazuki SudoJaffer A. Ajani Gastrointestinal Cancers (BG Czito, Section Editor) 26 January 2013 Pages: 146 - 151
Pathological Complete Response After Neoadjuvant Therapy for Rectal Cancer and the Role of Adjuvant Therapy Valerie M. NelsonAl B. Benson III Gastrointestinal Cancers (BG Czito, Section Editor) 05 February 2013 Pages: 152 - 161
Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer: An Emerging Paradigm? Thomas B. Brunner Gastrointestinal Cancers (BG Czito, Section Editor) 17 January 2013 Pages: 162 - 169
Anal Cancer: Are We Making Progress? Ajay AggarwalSimon DukeRob Glynne-Jones Gastrointestinal Cancers (BG Czito, Section Editor) 31 January 2013 Pages: 170 - 181
The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer Thierry ConroyCéline GavoilleMichel Ducreux Gastrointestinal Cancers (BG Czito, Section Editor) 23 January 2013 Pages: 182 - 189